ERIN COOKSEY HARRINGTON: Open Payments
NPI 1376675074 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,400 in 95 payments from 21 companies in 2025. Trend: 2023 $1,423 · 2024 $971 · 2025 $1,400
Food & beverage: $1,400
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $306 |
| Novo Nordisk Inc | 16 | $193 |
| AstraZeneca Pharmaceuticals LP | 7 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 23 | $175 |
| Lilly USA, LLC | 1 | $95 |
| Lundbeck LLC | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $61 |
| Eisai Inc. | 2 | $53 |
| Medtronic, Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
Products named: Kerendia, AIRSUPRA, UBRELVY, VRAYLAR, Ozempic, ZEPBOUND, Wegovy, XIFAXAN.
Industry payments across SC — which companies pay providers there.
